What does Mustang Bio, Inc. do?

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail…

What is Mustang Bio, Inc.'s P/E and P/B ratio?

Mustang Bio, Inc. has a P/E ratio of -0.8 and a P/B ratio of 0.37.

What is Mustang Bio, Inc.'s debt-to-equity ratio?

Mustang Bio, Inc. has a debt-to-equity ratio of 0.00.

How much does Mustang Bio, Inc. owe compared with what it owns?

Mustang Bio, Inc. owes $0.52 for every $1 it owns (balance sheet Jun 2026), which is moderate.

Does Mustang Bio, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Mustang Bio, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 17 Apr 2026). It has no yellow flags.

Where can I read the latest news about Mustang Bio, Inc.?

Recent headlines about Mustang Bio, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Mustang Bio, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Mustang Bio, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Mustang Bio, Inc.

Q: What is Mustang Bio, Inc.'s Positivity rank?

Mustang Bio, Inc. is ranked #2,809 of 6,774 companies globally and #1,017 of 4,000 in United States on PositoAI, with a Positivity Score of 21,120.

NasdaqCM: MBIO · Healthcare

Positivity Index

#2,809 / 6,774

Global

#1,017 / 4,000

United States

Positivity Score

21,120

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 17 Apr 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Mustang Bio, Inc. — Overview & Financial Snapshot

Mustang Bio, Inc. (NasdaqCM: MBIO) is a Healthcare company, ranked #2,809 of 6,774 companies globally and #1,017 of 4,000 in United States on PositoAI, with a Positivity Score of 21,120. Its market capitalisation is ₹26.41 Cr ($2.80M), P/E ratio is -0.8 and P/B ratio is 0.37. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →